| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biomarin Pharmaceutical Inc. (BMRN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. BMRN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 159.4K | $9.01M | - | |
| VP | 80.0K | $4.52M | - | |
| VP | 55.1K | $3.11M | - | |
| Dir | 49.4K | $2.79M | - | |
| Dir | 46.4K | $2.62M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2017 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sale+OE | 3,521 | $95.00 | $334,495.00 | -3.5% | |
| Sep 15, 2017 | Fuchs Henry J | President, Worldwide R&D | Sale+OE | 15,000 | $90.50 | $1,357,500.00 | -9.9% | |
| Sep 15, 2017 | Lawlis V Bryan53 | Director | Sale+OE | 3,750 | $91.26 | $342,225.00 | -19.1% | |
| Jun 23, 2017 | Davis George Eric64 | EVP, General Counsel | Sale+OE | 9,844 | $96.60 | $950,930.40 | -10.5% | |
| Jun 22, 2017 | Mueller Brian64 | SVP, Corporate Controller | Sale+OE | 2,671 | $100.00 | $267,100.00 | -17.2% | |
| Jun 19, 2017 | Fuchs Henry J | President, Worldwide R&D | Sale+OE | 15,000 | $90.00 | $1,350,000.00 | -3.5% | |
| Jun 16, 2017 | Lawlis V Bryan53 | Director | Sale+OE | 3,750 | $90.00 | $337,500.00 | -19.1% | |
| Jun 7, 2017 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sell | 1,004 | $89.61 | $89,968.44 | -2.1% | |
| Jun 5, 2017 | Davis George Eric64 | EVP, General Counsel | Sell | 9,471 | $91.04 | $862,230.37 | -11.3% | |
| Jun 5, 2017 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 10,000 | $90.13 | $901,300.00 | -2.1% |